Dr. Hoenle AG/ DE0005157101 /
21/09/2021 0:00:00 | Diferencia - | Volumen | Bid- | Ask- | Capitalización de mecado | Dividendo A. | P/E Ratio |
---|---|---|---|---|---|---|---|
51.6000USD | - | 1,000 Volumen de negocios: - |
-Volumen de oferta: - | -Tamaño/ Volumen/ Formato de Ask: - | 128.69 millonesUSD | - | - |
GlobeNewswire
2:25
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
GlobeNewswire
2:00
AST Mining Unveils Free Cloud Mining, Paving the Way for Seamless Crypto Investment in 2024.
GlobeNewswire
2:00
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Be...
GlobeNewswire
1:46
Telix Completes Proof-of-Concept Study of TLX592 Targeted Alpha Therapy in Prostate Cancer
GlobeNewswire
1:11
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages GoodRx Holdings, Inc. Investors to Secure Counsel Be...
Newsfile Corp
1:04
SEC Issues Exemptive Order Providing Additional Time for Certain Registrants to File Quarterly Repor...
GlobeNewswire
0:53
ROSEN, LEADING INVESTOR COUNSEL, Encourages Intel Corporation Investors to Secure Counsel Before Imp...
GlobeNewswire
0:15
Notre Dame de Namur University Announces the Appointment of Tseh-sien Kelly Vaughn, Ph.D. as Interim...
GlobeNewswire
0:05
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors to Secure Cou...
GlobeNewswire
0:00
Targa Resources Corp. to Participate in 21st Annual Energy Infrastructure CEO & Investor Conference
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página